Lucem Health Announces Series A Funding Round


Venture capital commitment for Mayo Clinic Platform portfolio company underscores promise of clinical AI to transform healthcare delivery

Lucem Health, a provider of clinical AI technology and solutions, has closed a Series A funding round of $7.7 million. Led by Mayo Clinic, Granger Management and Mercy (St Louis), this round builds on Lucem Health’s seed funding and includes financing from existing investor Rally Ventures.

The funding will be used to advance development of Lucem Health’s platform for clinical AI solution deployment, grow the company’s solution portfolio and expand its sales and marketing capacity.

The company helps clinical AI innovators transform data science into innovative, trusted solutions that can detect diseases earlier and optimize care delivery, positively impacting patient lives, improving the physician and provider experience, and ultimately producing improved outcomes.

“AI has tremendous potential to transform and augment how physicians and providers practice medicine, make decisions and serve their patients. Yet, so far, we have barely scratched the surface of AI’s potential in healthcare,” said Sean Cassidy, founding CEO of Lucem Health. “We started Lucem Health to accelerate integration of powerful AI-generated insights into care delivery workflows in a thoughtful, responsible way. In a challenging market for raising capital, we appreciate our investors’ confidence and support.”

Lucem Health recently launched Lucem Health Reveal, a family of solutions that identify patients who may be at a higher risk of serious or chronic diseases. Reveal solutions use readily available clinical data to surface previously undiscovered insights, helping physicians and providers deliver improved health outcomes for their patients and greater financial value to their organizations.